Skip to Content

Melphalan Injection and Tablets

Last Updated: May 17, 2011
Status: Resolved

Products Affected - Description

Alkeran Tablets and Injection, ApoPharma

Reason for the Shortage

  • ApoPharma acquired Alkeran from GlaxoSmithKline in October 2010 and had product on shortage during the transition period. ApoPharma is still waiting for licenses in some states. ApoPharma customer service at 1-866-931-0740 is available to help with obtaining product.
  • Bioniche could not provide a reason for the shortage.
  • Bedford has not launched melphalan injection at this time.

Estimated Resupply Dates

  • Bioniche has melphalan 50 mg injection (NDC 67470-0195-01) available.
  • ApoPharma has available Alkeran 50 mg injection (NDC 00173-0130-03) and 2 mg tablets (NDC 00173-0045-35).

Related Shortages


May 17, 2011; April 6, 2011; March 7, 2011; February 10, 2011; December 27, 2010; December 15, 2010; November 29, 2010, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.